Last reviewed · How we verify

NCT04852900

Different Dosage of Decompression Therapy on Symptoms of Lumbar Radiculopathy

Completed NA Last updated 6 August 2021
What this trial tests

NA trial testing Decompression with 30% in Lumbar Radiculopathy in 45 participants. Completed in 10 July 2021.

Timeline
14 October 2020
Primary endpoint
15 June 2021
10 July 2021

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment45
Start date14 October 2020
Primary completion15 June 2021
Estimated completion10 July 2021
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 30 to 50, any sex, with Lumbar Radiculopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will provide evidence about how much dose of decompression more effective for the treatment of lumbar radiculopathy. As this hypothesis has no evidence about the dosage of decompression in literature till now.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lumbar Radiculopathy

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04852900.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing